Drug Interaction Study of ASC42 With Atorvastatin
Clinical trial NCT05464628 · COMPLETED
Trial details
- NCT number
- NCT05464628
- Sponsor
- Gannex Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-08
- Primary completion
- 2022-08-23
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.